Filing Details

Accession Number:
0001193805-23-001003
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-18 18:50:53
Reporting Period:
2023-07-14
Accepted Time:
2023-07-18 18:50:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1768224 Arcturus Therapeutics Holdings Inc. ARCT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727317 Pad Chivukula C/O Arcturus Therapeutics Holdings Inc.
10628 Science Center Drive, Suite 250
San Diego CA 92121
Chief Scientific Officer & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-07-14 25,000 $35.01 519,448 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Reflects the weighted average price of 25,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on July 14, 2023, with sale prices ranging from $35.00 to $35.04 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.